Chinook Therapeutics Inc (NASDAQ:KDNY)

19.65
Delayed Data
As of Sep 30
 +0.17 / +0.87%
Today’s Change
10.48
Today|||52-Week Range
23.86
+20.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues73.0M50.7M17.2M15.1M
 
 
 
 
 
Depreciation And Amortization723.0K2.6M4.0M5.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses85.8M111.7M107.5M95.3M
 
 
 
 
 
Research And Development58.6M83.7M81.2M67.7M
 
 
 
 
 
Total Operating Expenses86.5M114.3M111.5M100.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.6M-63.6M-94.3M-85.1M
 
 
 
 
 
Extraordinary Charge-26.1M-8.3M-12.2M-16.2M
 
 
 
 
 
Other Expenses-161.0K-40.0K-218.0K-64.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.3M-69.7M-103.2M-96.1M
 
 
 
 
 
Income Taxes-99.0K-21.5M-11.4M-783.0K
 
 
 
 
 
Net Income-39.2M-91.1M-91.9M-95.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.7M65.2M72.9M78.8M
 
 
 
 
 
Shares To Calculate EPS Diluted44.7M65.2M72.9M78.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.88-$1.40-$1.26-$1.21
 
 
 
 
 
EPS Diluted-$0.88-$1.40-$1.26-$1.21